{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:37:18Z","timestamp":1792103838190,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"A*STAR","award":["RIE2020 and RIE2025 Industry-Alignment Fund \u2013 Industry Collaboration Projects (IAF-ICP) (Award I2001E0072 and I2501E0044)"],"award-info":[{"award-number":["RIE2020 and RIE2025 Industry-Alignment Fund \u2013 Industry Collaboration Projects (IAF-ICP) (Award I2001E0072 and I2501E0044)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05213-6","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T01:51:40Z","timestamp":1786153900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterisation of liver disease using quantitative MRI: report of the imaging arm of the ELEGANCE study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5820-5502","authenticated-orcid":false,"given":"Yi-Chun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oi Fong","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy Wei Song","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiha Binte","family":"Ithnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pik Eu Jason","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan Huei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Anastasia","family":"De Roza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalki R","family":"Chandrasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok Kiong","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Ching Yen","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee Tung","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngiap Chuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Lyn","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Yi","family":"Yeap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Chong","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl Min En","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacelyn Siou Sze","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade Shu Qi","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Ki","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Hui Rachel","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierce Kah Hoe","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"issue":"12","key":"5213_CR1","doi-asserted-by":"publisher","first-page":"101571","DOI":"10.1016\/j.jhepr.2025.101571","volume":"7","author":"E Mauro","year":"2025","unstructured":"Mauro E, de Castro T, Zeitlhoefler M, Sung MW, Villanueva A, Mazzaferro V, et al. Hepatocellular carcinoma: Epidemiology, diagnosis and treatment. JHEP Rep. 2025;7(12):101571. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101571.","journal-title":"JHEP Rep"},{"issue":"3","key":"5213_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"5213_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3350\/cmh.2023.0004","volume":"29","author":"YJ Wong","year":"2023","unstructured":"Wong YJ, Nguyen VH, Yang HI, Li J, Le MH, Wu WJ, et al. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis. Clin Mol Hepatol. 2023;29(3):705\u201320. https:\/\/doi.org\/10.3350\/cmh.2023.0004 . PubMed PMID: 37157776; PubMed Central PMCID: PMC10366810.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"5213_CR4","doi-asserted-by":"publisher","first-page":"e1001624","DOI":"10.1371\/journal.pmed.1001624","volume":"11","author":"AG Singal","year":"2014","unstructured":"Singal AG, Pillai A, Tiro J, Early, Detection. Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis. PLOS Med. 2014;11(4):e1001624. https:\/\/doi.org\/10.1371\/journal.pmed.1001624.","journal-title":"PLOS Med"},{"issue":"6","key":"5213_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, et al. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024;390(6):497\u2013509. doi:10.1056\/NEJMoa2309000 PubMed PMID: 38324483.","journal-title":"N Engl J Med"},{"issue":"11","key":"5213_CR6","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.cgh.2021.09.041","volume":"20","author":"A Andersson","year":"2022","unstructured":"Andersson A, Kelly M, Imajo K, Nakajima A, Fallowfield JA, Hirschfield G, et al. Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis. Clin Gastroenterol Hepatol. 2022;20(11):2451\u2013e24613. https:\/\/doi.org\/10.1016\/j.cgh.2021.09.041.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"5213_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhep.2013.09.002","volume":"60","author":"R Banerjee","year":"2014","unstructured":"Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol. 2014;60(1):69\u201377. PubMed PMID: 24036007; PubMed Central PMCID: PMC3865797.","journal-title":"J Hepatol"},{"issue":"7","key":"5213_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3748\/wjg.v27.i7.609","volume":"27","author":"K Imajo","year":"2021","unstructured":"Imajo K, Tetlow L, Dennis A, Shumbayawonda E, Mouchti S, Kendall TJ, et al. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort. World J Gastroenterol. 2021;27(7):609\u201323. https:\/\/doi.org\/10.3748\/wjg.v27.i7.609.","journal-title":"World J Gastroenterol"},{"key":"5213_CR9","doi-asserted-by":"publisher","unstructured":"Bachtiar V, Kelly MD, Wilman HR, Jacobs J, Newbould R, Kelly CJ et al. Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver. Lundberg P, editor. PLOS ONE. 2019;14(4):e0214921. https:\/\/doi.org\/10.1371\/journal.pone.0214921.","DOI":"10.1371\/journal.pone.0214921"},{"key":"5213_CR10","doi-asserted-by":"publisher","unstructured":"Mojtahed A, N\u00fa\u00f1ez L, Connell J, Fichera A, Nicholls R, Barone A, et al. Repeatability and reproducibility of deep-learning-based liver volume and Couinaud segment volume measurement tool. Abdom Radiol. 2021 Oct;4. https:\/\/doi.org\/10.1007\/s00261-021-03262-x.","DOI":"10.1007\/s00261-021-03262-x"},{"issue":"5","key":"5213_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00534-005-0999-7","volume":"12","author":"SM Strasberg","year":"2005","unstructured":"Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 2005;12(5):351\u20135. https:\/\/doi.org\/10.1007\/s00534-005-0999-7.","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"4","key":"5213_CR12","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.29639","volume":"67","author":"C Caussy","year":"2018","unstructured":"Caussy C, Alquiraish MH, Nguyen P, Hernandez C, Cepin S, Fortney LE, et al. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology. 2018;67(4):1348\u201359. https:\/\/doi.org\/10.1002\/hep.29639.","journal-title":"Hepatology"},{"issue":"5","key":"5213_CR13","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jhep.2023.05.046","volume":"79","author":"A Roca-Fernandez","year":"2023","unstructured":"Roca-Fernandez A, Banerjee R, Thomaides-Brears H, Telford A, Sanyal A, Neubauer S, et al. Liver disease is a significant risk factor for cardiovascular outcomes \u2013 A UK Biobank study. J Hepatol. 2023;79(5):1085\u201395. https:\/\/doi.org\/10.1016\/j.jhep.2023.05.046 . PubMed PMID: 37348789.","journal-title":"J Hepatol"},{"issue":"7","key":"5213_CR14","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1038\/s41591-025-03654-2","volume":"31","author":"E Jackson","year":"2025","unstructured":"Jackson E, Dennis A, Alkhouri N, Samala N, Vuppalanchi R, Sanyal AJ, et al. Cardiac and liver impairment on multiorgan MRI and risk of major adverse cardiovascular and liver events. Nat Med. 2025;31(7):2289\u201396. https:\/\/doi.org\/10.1038\/s41591-025-03654-2.","journal-title":"Nat Med"},{"key":"5213_CR15","unstructured":"Health Protection Board Singapore. Weight Management Guidelines [Internet]. 2025 [cited 2025 Oct 14]. Available from: https:\/\/www.hpb.gov.sg\/docs\/default-source\/newsroom\/wm-guidelines.pdf?sfvrsn=12f9fe72_2"},{"issue":"4","key":"5213_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jhep.2020.05.040","volume":"73","author":"LY Mak","year":"2020","unstructured":"Mak LY, Hui RWH, Fung J, Liu F, Wong DKH, Cheung KS, et al. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B. J Hepatol. 2020;73(4):800\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2020.05.040.","journal-title":"J Hepatol"},{"issue":"2","key":"5213_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.14309\/ajg.0000000000002915","volume":"120","author":"SC Huang","year":"2025","unstructured":"Huang SC, Su TH, Tseng TC, Liao SH, Hsu SJ, Hong CM, et al. Pre-Existing and New-Onset Metabolic Dysfunctions Increase Cirrhosis and Its Complication Risks in Chronic Hepatitis B. Am J Gastroenterol. 2025;120(2):401\u20139. https:\/\/doi.org\/10.14309\/ajg.0000000000002915 . PubMed PMID: 38920306.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"5213_CR18","doi-asserted-by":"publisher","first-page":"101507","DOI":"10.1016\/j.aohep.2024.101507","volume":"29","author":"A Nakamura","year":"2024","unstructured":"Nakamura A, Yoshimura T, Ichikawa T, Okuyama K. Prognostic significance of low hepatic fat content in advanced chronic liver disease: MRI-PDFF insights. Ann Hepatol. 2024;29(4):101507. https:\/\/doi.org\/10.1016\/j.aohep.2024.101507.","journal-title":"Ann Hepatol"},{"issue":"4","key":"5213_CR19","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VII, Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.022 . PubMed PMID: 35120736; PubMed Central PMCID: PMC11090185.","journal-title":"J Hepatol"},{"issue":"1","key":"5213_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/apt.70403","volume":"63","author":"NSY Tang","year":"2026","unstructured":"Tang NSY, Gunalan S, Ong CEY, Koh B, Tham EKJ, Lim RY, et al. Meta-Analysis: Utilisation of Hepatocellular Carcinoma Surveillance. Aliment Pharmacol Ther. 2026;63(1):8\u201316. https:\/\/doi.org\/10.1111\/apt.70403 . PubMed PMID: 41077883.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"5213_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3350\/cmh.2022.0181","volume":"29","author":"YJ Wong","year":"2023","unstructured":"Wong YJ, Zhaojin C, Tosetti G, Degasperi E, Sharma S, Agarwal S, et al. Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients. Clin Mol Hepatol. 2023;29(1):135\u201345. https:\/\/doi.org\/10.3350\/cmh.2022.0181.","journal-title":"Clin Mol Hepatol"},{"key":"5213_CR22","doi-asserted-by":"publisher","unstructured":"Huang DQ, Singal AG, Kanwal F, Lampertico P, Buti M, Sirlin CB, et al. Hepatocellular carcinoma surveillance \u2014 utilization, barriers and the impact of changing aetiology. Nat Rev Gastroenterol Hepatol. 2023;1\u201313. https:\/\/doi.org\/10.1038\/s41575-023-00818-8.","DOI":"10.1038\/s41575-023-00818-8"},{"issue":"1","key":"5213_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cgh.2022.01","volume":"21","author":"VWS Wong","year":"2023","unstructured":"Wong VWS, Tak WY, Goh GBB, Cheng PN, Lawitz EJ, Younossi ZM, et al. Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials. Clin Gastroenterol Hepatol. 2023;21(1):90\u2013e1026. https:\/\/doi.org\/10.1016\/j.cgh.2022.01. .015 PubMed PMID: 35074532.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"5213_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/HEP.0000000000000891","volume":"81","author":"YJ Wong","year":"2025","unstructured":"Wong YJ, Chen VL, Abdulhamid A, Tosetti G, Navadurong H, Kaewdech A, et al. Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients. Hepatol Baltim Md. 2025;81(2):523\u201331. 10. 1097\/HEP.0000000000000891 PubMed PMID: 38630497.","journal-title":"Hepatol Baltim Md"},{"issue":"11","key":"5213_CR25","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1007\/s10620-024-08683-4","volume":"69","author":"T Goyal","year":"2024","unstructured":"Goyal T, Song MW, Suresh D, Jasty VSJ, Urias E, Wijarnpreecha K, et al. Serial Liver Stiffness Measurement and Fibrosis-4 Scores in Metabolic Dysfunction-Associated Steatotic Liver Disease. Dig Dis Sci. 2024;69(11):4250\u20138. https:\/\/doi.org\/10.1007\/s10620-024-08683-4 . PubMed PMID: 39407080.","journal-title":"Dig Dis Sci"},{"key":"5213_CR26","doi-asserted-by":"publisher","unstructured":"Ndaa M, Pandya PK, Swensson J, Samala N, Ajaz S, Joshi D, et al. Reliable Monitoring of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease Using Imaging: A Systematic Literature Review and Meta-Analysis on Measurement Repeatability. Endocr Pract. 2025 Oct;1. https:\/\/doi.org\/10.1016\/j.eprac.2025.09.205.","DOI":"10.1016\/j.eprac.2025.09.205"},{"key":"5213_CR27","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/JHC.S544589","volume":"12","author":"QB Wang","year":"2025","unstructured":"Wang QB, Luo WL, Li YK, Li J, Yang ZS, Zhao K, et al. Tumor Compression of the Hepatic or Portal Vein Predicts the Presence of Microvascular Invasion and Satellite Nodules in Hepatocellular Carcinoma: A Retrospective Study. J Hepatocell Carcinoma. 2025;12:2055\u201367. .S544589 PubMed PMID: 40963958; PubMed Central PMCID: PMC12439820.","journal-title":"J Hepatocell Carcinoma"},{"issue":"3","key":"5213_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cgh.2023.09","volume":"22","author":"SC Huang","year":"2024","unstructured":"Huang SC, Su TH, Tseng TC, Chen CL, Hsu SJ, Liu CH, et al. Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion. Clin Gastroenterol Hepatol Off Clin Pract. J Am Gastroenterol Assoc. 2024;22(3):581\u2013e5906. https:\/\/doi.org\/10.1016\/j.cgh.2023.09. .040 PubMed PMID: 37871842.","journal-title":"J Am Gastroenterol Assoc"},{"issue":"1","key":"5213_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jhep.2024.12.009","volume":"83","author":"SC Huang","year":"2025","unstructured":"Huang SC, Su TH, Tseng TC, Hsu SJ, Hong CM, Lan TY, et al. All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver disease. J Hepatol. 2025;83(1):43\u201351. https:\/\/doi.org\/10.1016\/j.jhep.2024.12.009 . PubMed PMID: 39675434.","journal-title":"J Hepatol"},{"issue":"Suppl","key":"5213_CR30","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32\u201350. https:\/\/doi.org\/10.3350\/cmh. 2024.0431 PubMed PMID: 39159948; PubMed Central PMCID: PMC11925440.","journal-title":"Clin Mol Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05213-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:32:33Z","timestamp":1789630353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05213-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5213"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05213-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"29 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All research in this study was conducted in accordance with both the Declarations of Helsinki and Istanbul. This study protocol was reviewed and approved by the SingHealth Institutional Review Board (IRB) ECOS Ref. 2020\/3053. More information about the regulatory approvals is available upon request to the corresponding author. Prior to data collection, Informed Consent was obtained from all participants. Before enrolment, the participating physician or delegated site personnel must explain to potential participant of their involvement in the study. Participants were informed that their participation in the study is voluntary and that they may withdraw consent at any time. They were informed that choosing not to participate in this study will not affect the standard of care the patient will receive. The patient was given sufficient time to read the ICF (in a language that the patient can read and understand) and was given the opportunity to ask questions. Consent was appropriately recorded by means of the patient\u2019s personally dated signature.Written informed consent was obtained from all participants prior to their inclusion in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent for publication of de-identified data arising from this study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PKHC received honoraria from La Hoffman-Roche, Sirtex Medical; research funding from Sirtex Medical, Ipsen, IQVIA, New B Innovation, AMiLi, Perspectum, MiRXES, La Hoffman-Roche; holds a consultancy or advisory role in Sirtex Medical, Ipsen, BMS, Oncosil, Bayer, New B Innovation, MSD, Guerbet, Roche, AUM Bioscience, L.E.K. Consulting, AstraZeneca, Eisai, Genentech, IQVIA, Abbott. YCW, EJ, AD, SR, MB are employees of Perspectum. MB is a founder of Perspectum.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"576"}}